Dogwood Therapeutics, Inc.·4

Dec 5, 4:05 PM ET

Walsh Angela 4

4 · Dogwood Therapeutics, Inc. · Filed Dec 5, 2025

Insider Transaction Report

Form 4
Period: 2025-12-04
Walsh Angela
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2025-12-04+150,000150,000 total
    Exercise: $6.14Exp: 2035-12-04Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]The stock option vests one-third on December 4, 2026 and 1/24th monthly thereafter.

Documents

1 file
  • 4
    form4-12052025_041205.xmlPrimary